The incidence of lower respiratory tract infections and pneumococcal vaccination status in adults in flemish primary care.

Acta Clinica Belgica
Tine De BurghgraeveCatharina Mathei

Abstract

Pneumococcal vaccination coverage of adults at risk for pneumococcal disease is below recommended levels. There is no observational data on pneumococcal vaccination and the incidence of lower respiratory tract infections in a general adult population. The current study had the objective to explore the incidence of lower respiratory tract infections and the pneumococcal vaccine coverage in function of age, influenza vaccination status and risk status, in Flanders, Belgium. We used data from Intego, ageneral practice-based morbidity registration network in Flanders (Belgium). We gathered data on pneumococcal vaccinations, influenza vaccination (in 2014) and ICPC2-coded diagnoses of pneumonia and acute bronchitis (2015). First, we divided the population into three groups along the risk status for developing apneumococcal infection according to the recommendations for pneumococcal vaccination in adults by the Belgian High Council of Health. 28.6% from our total adult study population are considered the target group for vaccination. Second, we found that the average pneumococcal vaccination coverage in this targeted population was 18.7%. Third, we found asignificantly higher incidence of LRTI in patients previously vaccinated agains...Continue Reading

References

Jun 21, 2005·Family Practice·Stefaan BartholomeeusenFrank Buntinx
Jun 3, 2006·Epidemiology and Infection·P MangtaniJ A Roberts
Sep 28, 2007·The Lancet Infectious Diseases·Lone SimonsenLisa A Jackson
Jun 11, 2009·Vaccine·José-María BayasAngela Domínguez
Aug 6, 2011·Respiratory Medicine·Georgia G Pitsiou, Ioannis P Kioumis
Dec 18, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M H RozenbaumE Hak
Dec 19, 2012·Médecine et maladies infectieuses·E RouveixUNKNOWN l’intergroupe Société de pathologie infectieuse de langue française/Société de gériatrie et gérontologie clinique (SPILF/SGG
Jan 16, 2013·Pharmacoepidemiology and Drug Safety·Lamiae Grimaldi-BensoudaUNKNOWN PGRx Study Group
Jan 26, 2013·The European Respiratory Journal·Saskia F van VugtUNKNOWN GRACE Project Group
Sep 27, 2013·Influenza and Other Respiratory Viruses·Carol JosephNahoko Shindo
Dec 26, 2013·International Journal of Environmental Research and Public Health·Sarah HoeckGuido Van Hal
Feb 18, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Olga Ochoa-GondarImma Hospital-Guardiola
May 9, 2014·Chest·Salvador BelloJuan Ruiz-Manzano
Jul 22, 2014·The Lancet Infectious Diseases·Angel Vila-Corcoles, Olga Ochoa-Gondar
Mar 4, 2015·Open Forum Infectious Diseases·Kimberly M SheaStephen I Pelton
Mar 19, 2015·The New England Journal of Medicine·Marc J M BontenDiederick E Grobbee
Apr 30, 2015·Archives of public health = Archives belges de santé publique·Françoise RenardPatrick Deboosere
Feb 16, 2017·Current Opinion in Pulmonary Medicine·Ricardo J José, Jeremy S Brown

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.